Some bispecific antibody therapies link immune T cells directly to cancer cells. One arm of the bispecific attaches to a T cell. The other arm attaches to the cancer cell. This connection activates the T cell to release proteins that kill the cancer cell.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your World Cancer Day gift can go 2X as far.